Gianmaria Baldin

1.1k total citations
50 papers, 457 citations indexed

About

Gianmaria Baldin is a scholar working on Infectious Diseases, Virology and Emergency Medicine. According to data from OpenAlex, Gianmaria Baldin has authored 50 papers receiving a total of 457 indexed citations (citations by other indexed papers that have themselves been cited), including 42 papers in Infectious Diseases, 30 papers in Virology and 12 papers in Emergency Medicine. Recurrent topics in Gianmaria Baldin's work include HIV/AIDS drug development and treatment (36 papers), HIV Research and Treatment (29 papers) and HIV/AIDS Research and Interventions (21 papers). Gianmaria Baldin is often cited by papers focused on HIV/AIDS drug development and treatment (36 papers), HIV Research and Treatment (29 papers) and HIV/AIDS Research and Interventions (21 papers). Gianmaria Baldin collaborates with scholars based in Italy, Japan and United States. Gianmaria Baldin's co-authors include Arturo Ciccullo, Gaetana Sterrantino, Alberto Borghetti, Amedeo Capetti, Stefano Rusconi, Maria Vittoria Cossu, Simona Di Giambenedetto, Simona Di Giambenedetto, Francesca Lombardi and Andrea De Luca and has published in prestigious journals such as SHILAP Revista de lepidopterología, PLoS ONE and Clinical Infectious Diseases.

In The Last Decade

Gianmaria Baldin

42 papers receiving 452 citations

Peers

Countries citing papers authored by Gianmaria Baldin

Since Specialization

Citations

This map shows the geographic impact of Gianmaria Baldin's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Gianmaria Baldin with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Gianmaria Baldin more than expected).

Fields of papers citing papers by Gianmaria Baldin

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Gianmaria Baldin. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Gianmaria Baldin. The network helps show where Gianmaria Baldin may publish in the future.

Co-authorship network of co-authors of Gianmaria Baldin

This figure shows the co-authorship network connecting the top 25 collaborators of Gianmaria Baldin. A scholar is included among the top collaborators of Gianmaria Baldin based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Gianmaria Baldin. Gianmaria Baldin is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Assessing dengue seroprevalence among people living with HIV (PLWH) in rome, Italy: Insights from the 2023 Italian autochthonous outbreak 2025 ·Travel Medicine and Infectious Disease ·(unknown), Francesca Lombardi, (unknown), (unknown), Gianmaria Baldin, Alberto Borghetti, Carlo Torti, Simona Di Giambenedetto	0
2	Impact of HBV serological status on HIV virological efficacy of two‐drug antiretroviral regimens: A retrospective observational study on virologically suppressed people with HIV switching to lamivudine/dolutegravir 2025 ·HIV Medicine ·(unknown), Arturo Ciccullo, Elena Visconti, Francesca Lombardi, Carlo Torti, Simona Di Giambenedetto, Gianmaria Baldin	0
3	Investigating seroprevalence of IgG antibodies against Monkeypox Virus (MPXV) in a cohort of people living with HIV (PLWH) in Rome, during the 2022 outbreak: Moving beyond traditional at-risk populations 2024 ·Travel Medicine and Infectious Disease ·(unknown), (unknown), Gianmaria Baldin, (unknown), Arturo Ciccullo, (unknown), Domenico Benvenuto, Alberto Borghetti, Simona Di Giambenedetto, Francesca Lombardi	1
4	Comparing the long-term effectiveness and safety of dolutegravir/lamivudine versus bictegravir/emtricitabine/tenofovir alafenamide fumarate as first-line regimens: a real life multicentre cohort 2024 ·Journal of Antimicrobial Chemotherapy ·Arturo Ciccullo, Gianmaria Baldin, (unknown), Davide Moschese, Filippo Lagi, Maria Vittoria Cossu, (unknown), Andrea Giacomelli, Stefano Rusconi, Gaetana Sterrantino, Alberto Borghetti, Spinello Antinori, Cristina Mussini, Simona Di Giambenedetto	2
5	Cardiovascular Safety of Doravirine/Lamivudine/Tenofovir Disoproxil Fumarate in Virologically Suppressed PLWHIV: A Comparative Analysis of CVD Scores 2024 ·AIDS Research and Human Retroviruses ·Arturo Ciccullo, (unknown), (unknown), (unknown), Francesca Lombardi, (unknown), (unknown), Gianmaria Baldin, Alberto Borghetti, Simona Di Giambenedetto	2
6	Efficacy and Durability of Dolutegravir- or Darunavir-Based Regimens in ART-Naïve AIDS- or Late-Presenting HIV-Infected Patients 2023 ·Viruses ·Massimiliano Fabbiani, (unknown), Barbara Rossetti, Arturo Ciccullo, Vanni Borghi, Filippo Lagi, Amedeo Capetti, Manuela Colafigli, (unknown), Gianmaria Baldin, Cristina Mussini, Gaetana Sterrantino, (unknown), Francesca Montagnani, Mario Tumbarello, Simona Di Giambenedetto	4
7	Real-Life Impact of Drug Toxicity on Dolutegravir Tolerability: Clinical Practice Data from a Multicenter Italian Cohort 2022 ·Viruses ·Arturo Ciccullo, Gianmaria Baldin, Vanni Borghi, Filippo Lagi, Alessandra Latini, Gabriella d’Ettorre, Letizia Oreni, (unknown), Amedeo Capetti, Massimiliano Fabbiani, Andrea Giacomelli, Alessandro Grimaldi, Giordano Madeddu, Gaetana Sterrantino, Cristina Mussini, Simona Di Giambenedetto	7
8	Analysing the efficacy and tolerability of dolutegravir plus either rilpivirine or lamivudine in a multicentre cohort of virologically suppressed PLWHIV 2022 ·Journal of Antimicrobial Chemotherapy ·Arturo Ciccullo, Gianmaria Baldin, Vanni Borghi, Maria Vittoria Cossu, Andrea Giacomelli, Filippo Lagi, (unknown), (unknown), (unknown), (unknown), Gaetana Sterrantino, Cristina Mussini, Spinello Antinori, Simona Di Giambenedetto	5
9	Cardiovascular Disease Risk in a Cohort of Virologically Suppressed People Living with HIV Switching to Doravirine: Preliminary Data from the Real Life 2022 ·AIDS Research and Human Retroviruses ·(unknown), (unknown), (unknown), (unknown), (unknown), (unknown), Gianmaria Baldin, Elena Visconti, Enrica Tamburrini, Alberto Borghetti, Simona Di Giambenedetto, Arturo Ciccullo	8
10	Seroprevalence of SARS-CoV-2 Antibodies in HIV-Infected Patients in Rome, Italy during the COVID-19 Outbreak 2021 ·Diagnostics ·Francesca Lombardi, (unknown), (unknown), Massimiliano Fabbiani, Alberto Borghetti, Gianmaria Baldin, Arturo Ciccullo, Enrica Tamburrini, Elena Visconti, Maurizio Sanguinetti, Simona Di Giambenedetto	6
11	Dolutegravir plus lamivudine for the treatment of HIV-1 infection 2020 ·Expert Review of Anti-infective Therapy ·Arturo Ciccullo, Gianmaria Baldin, Alberto Borghetti, Simona Di Giambenedetto	7
12	Shall We Dance? Extending TANGO’s Results to Clinical Practice 2020 ·Clinical Infectious Diseases ·Alberto Borghetti, Arturo Ciccullo, Gianmaria Baldin, Stefano Rusconi, Amedeo Capetti, Gaetana Sterrantino, William Gennari, Cristina Mussini, Vanni Borghi, Simona Di Giambenedetto	9
13	Transmitted drug resistance to NRTIs and risk of virological failure in naïve patients treated with integrase inhibitors 2020 ·HIV Medicine ·Alberto Borghetti, Arturo Ciccullo, Francesca Lombardi, Gianmaria Baldin, (unknown), Mattia Prosperi, Francesca Incardona, Eva Heger, Vanni Borghi, Anders Sönnerborg, Maurizio Zazzi, Andrea De Luca, Simona Di Giambenedetto	6
14	Single tablet regimen with abacavir/lamivudine/dolutegravir compared with two-drug regimen with lamivudine and dolutegravir as different strategies of simplification from a multicenter HIV cohort study. 2019 ·PubMed ·Gianmaria Baldin, Arturo Ciccullo, Stefano Rusconi, Giordano Madeddu, Gaetana Sterrantino, Andrew N. Freedman, (unknown), Luigi Celani, Alessandra Latini, Barbara Rossetti, Maria Vittoria Cossu, Andrea Giacomelli, Filippo Lagi, Amedeo Capetti, Simona Di Giambenedetto	6
15	Reduced soluble CD14 levels after switching from a dual regimen with lamivudine plus boosted protease inhibitors to lamivudine plus dolutegravir in virologically suppressed HIV-infected patients 2019 ·SHILAP Revista de lepidopterología ·Francesca Lombardi, (unknown), Alberto Borghetti, Arturo Ciccullo, Gianmaria Baldin, Roberto Cauda, Massimiliano Fabbiani, Simona Di Giambenedetto	11
16	Long-term data on the efficacy and tolerability of lamivudine plus dolutegravir as a switch strategy in a multi-centre cohort of HIV-1-infected, virologically suppressed patients 2019 ·International Journal of Antimicrobial Agents ·Gianmaria Baldin, Arturo Ciccullo, Stefano Rusconi, Amedeo Capetti, Gaetana Sterrantino, Manuela Colafigli, Gabriella d’Ettorre, (unknown), Maria Vittoria Cossu, Alberto Borghetti, William Gennari, Cristina Mussini, Vanni Borghi, Simona Di Giambenedetto	40
17	Changes in bone mineral density in HIV-positive, virologically suppressed patients switching to lamivudine/dolutegravir dual therapy: preliminary results from clinical practice. 2018 ·PubMed ·Arturo Ciccullo, A D’Avino, (unknown), Gianmaria Baldin, Alberto Borghetti, (unknown), Arianna Emiliozzi, Roberta Gagliardini, Davide Moschese, (unknown), Francesca Lombardi, Simona Di Giambenedetto	10
18	Efficacy and tolerability of lamivudine plus dolutegravir as a switch strategy in a multicentre cohort of patients with suppressed HIV‐1 replication 2018 ·HIV Medicine ·Alberto Borghetti, Gianmaria Baldin, Francesca Lombardi, Arturo Ciccullo, Amedeo Capetti, Stefano Rusconi, Gaetana Sterrantino, Alessandra Latini, Maria Vittoria Cossu, Roberta Gagliardini, Andrea De Luca, Simona Di Giambenedetto	37
19	Efficacy and safety of switching to dolutegravir plus emtricitabine/tenofovir disoproxil fumarate (TDF) or elvitegravir/cobicistat/emtricitabine/TDF in virologically suppressed HIV‐infected patients in clinical practice: results from a multicentre, observational study 2018 ·HIV Medicine ·Gianmaria Baldin, Arturo Ciccullo, Amedeo Capetti, Stefano Rusconi, Gaetana Sterrantino, Maria Vittoria Cossu, Andrea Giacomelli, Filippo Lagi, Alessandra Latini, Paola Bagella, Andrea De Luca, Simona Di Giambenedetto, Giordano Madeddu	14
20	An outbreak of acute hepatitis A among young adult men: clinical features and HIV coinfection rate from a large teaching hospital in Rome, Italy 2018 ·HIV Medicine ·Arturo Ciccullo, Roberta Gagliardini, Gianmaria Baldin, Alberto Borghetti, Davide Moschese, Arianna Emiliozzi, Francesca Lombardi, Renato Pietro Ricci, Domenico Speziale, Federica Pallavicini, Simona Di Giambenedetto	10

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact